Online inquiry

IVTScrip™ mRNA-Human ANKRD13D, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19701MR)

This product GTTS-WK19701MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD13D protein. This product can be used in Multilymphoid progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001347901.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 338692
UniProt ID Q6ZTN6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD13D, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19701MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK21716MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF3
GTTS-WK7274MR IVTScrip™ mRNA-Human ABI2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ABI2
GTTS-WK19104MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD18A
GTTS-WK25702MR IVTScrip™ mRNA-Human ASCC1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASCC1
GTTS-WK21321MR IVTScrip™ mRNA-Human AHI1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AHI1
GTTS-WK26234MR IVTScrip™ mRNA-Human ARL13B, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK21511MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD26P1
GTTS-WK13799MR IVTScrip™ mRNA-Human AGGF1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AGGF1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW